LCN2 and Stroke: Nevertheless, targeting LCN2 to blunt post-stroke neuroinflammation may be more advantageous than inhibiting individual cytokines and chemokines because LCN2 is likely an important upstream regulator of these mediators in the inflammatory cascade.